Trendlyne Blog: , Latest on stock market and finance in India and the world.

Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets

IND

USA

Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding

Mankind Pharma Ltd.

20 May 2025

2448.00

0.34%

Mankind Pharma Q4 Results Preview: Tariff-Related Risks, Potential Margin Pressure In Focus

NDTV Profit

As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the March quarter is expected to rise 26.8% year-on-year to Rs 3,095.7 crore, compared to Rs 2,441.10 crore a year ago.

Copy LinkShare on

Share on Share on Share on

Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.

Gland Pharma Ltd.

19 May 2025

1951.40

-1.52%

Gland Pharma Q4 Results Preview: US Pick Up, New Launches, Cenexi Recovery To Offset Seasonal Weakness

NDTV Profit

As per Bloomberg estimates, Gland Pharma's consolidated revenue for the March quarter is expected to rise 0.9% year-on-year to Rs 1,551.73 crore, compared to Rs 1,537.45 crore a year ago.

Copy LinkShare on

Share on Share on Share on

Gland Pharma Ltd. is trading below its 50 day SMA of 1966.5

Blue Jet Healthcare Ltd

17 May 2025

663.35

0.26%

Blue Jet Healthcare Expects To Maintain FY26 Ebitda Margin In Mid-30s

NDTV Profit

Contrast media is the company's flagship segment and will continue to be its mainstay, according to Blue Jet Healthcare COO, VK Singh.

Copy LinkShare on

Share on Share on Share on

Blue Jet Healthcare Ltd has gained 34.46% in the last 1 Year

Dr. Reddy's Laboratories Ltd.

17 May 2025

1248.10

0.27%

Dr Reddy's Gets Two Observations From US FDA For New York API Plant

NDTV Profit

The inspection was conducted during May 12-16, 2025, it added.

Copy LinkShare on

Share on Share on Share on

Dr. Reddy's Laboratories Ltd. average weekly volume is high.

Dr Reddy's receives two USFDA observations for API facility in New York

Business Line | 17 May 2025

GlaxoSmithKline Pharmaceuticals Ltd.

16 May 2025

2745.80

1.80%

Fire disrupts production at GSK Pharma's contract manufacturing site

Business Standard

GSK Pharmaceuticals has reported a fire at one of its contract sites, causing temporary disruption; the company is assessing the impact and working to restore operations

Copy LinkShare on

Share on Share on Share on

GlaxoSmithKline Pharmaceuticals Ltd. is trading below its 30 day SMA of 2765.3

Sun Pharmaceutical Industries Ltd.

16 May 2025

1631.20

-0.31%

Sun Pharma gets USFDA approval for new device to treat skin disease

Business Standard

The company says that the new device is more compact and easier to use than its predecessor

Copy LinkShare on

Share on Share on Share on

Sun Pharmaceutical Industries Ltd. is trading below its 100 day SMA of 1655.5

Alkem Laboratories Ltd.

16 May 2025

5442.00

-0.32%

Alkem reports cyber security incident at Enzene's US subsidiary

Business Line

The incident resulted in a fraudulent transfer of funds

Copy LinkShare on

Share on Share on Share on

Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.

Aurobindo Pharma Ltd.

16 May 2025

1093.30

0.67%

Aurobindo Pharma's arm teams up with IMT Hyderabad for leadership development

Business Line

This program is an important step in grooming our middle managers to take on larger responsibilities with confidence and agility,' Vice President, Corporate HR, Aurobindo Pharma

Copy LinkShare on

Share on Share on Share on

Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings